 |
 |
 |
 |
 |
|
Chief |
Kentaro Yamazaki, M.D., Ph.D. |
Satoshi, Hamauchi, M.D. |
Tomoya Yokota, M.D., Ph.D. |
Kazushige Wakuda, M.D., Ph.D. |
 |
 |
 |
 |
 |
|
Ryo Ko, M.D., Ph.D. |
Nahomi Tokudome, M.D., Ph.D. |
Akiko Shibatani (Furusawa), M.D., Ph.D. (Also Serving as Senior Staff, Div. of Gynecology) |
Masashi Niwakawa, M.D., Ph.D. |
Shusuke Yoshizawa, M.D. |
 |
 |
 |
 |
|
|
Takeshi Aramaki, M.D. |
Junji Wasa, M.D., Ph.D. |
Yuji Ishida, M.D. |
Yusuke Onozawa, M.D. |
This is a new clinical division launched in April, 2024. It specializes in early clinical development for anti-malignant tumor drugs. The phase I clinical trial is the very first step for a clinical development of a new anti-cancer drug. That’s when safety as well as efficacy of the drug are evaluated, and optimal dose and administration method are studied and discussed. At this early stage of the clinical development, the subject is often targeted to a wide range of malignant tumors, rather than a specific type of tumor or an organ, which makes it more sensible to have a cross-organ research system than otherwise. In addition, as a newly-developed anti-cancer drug has an action mechanism different from conventional anti-cancer drugs, side effect management will also be beyond the scope of conventional ones. At the SCC, we have already had interprofessional collaborations among doctors and nurses at various clinical divisions, pharmacists, clinical test coordinators, etc. for the early clinical developments including the phase I clinical trials. However, now that the Division of Early Clinical Development has been established, a ward dedicated for the treatment management is prepared, the medical staff equipped with expertism and ample experiences in the field is stationed there, and the developments are being carried out much safer and faster than before.
In recent years, cancer genome profiling analysis has been clinically introduced, and new therapies focusing on specific gene abnormalities have been prominently developed ever since. At the same time, the cases where the efficacies of those therapies are proven at the early stages of clinical developments have been increasing. This division works closely together with the Genomic Medicine Support Office to promote early clinical development of an effective new anti-cancer drug based on the results of cancer genome profiling analyses, aiming at the benefits of cancer patients by delivering it as fast as possible.
chemotherapy for lung cancer
clinical oncology
Certified Physician and Specialist, the Japanese Society of Internal Medicine
The Japanese Society of Medical Oncology
Specialist and Supervisory Doctor Certified by the Japanese Respiratory Society
The Japanese Cancer Association
The Japan Lung Cancer Society
The Japan Society of Clinical Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The American Society of Clinical Oncology (ASCO)
chemotherapy for gastrointestinal cancer (colorectal cancer)
Certified Physician, the Japanese Society of Internal Medicine
The Japan Gastroenterological Endoscopy Society
The Japan Society of Clinical Oncology
The Japanese Society of Gastroenterology
The Japanese Society of Medical Oncology
The Japan Society of Coloproctology
The Japanese Association for Molecular Target Therapy of Cancer
The American Society of Clinical Oncology (ASCO）
The European Society for Clinical Oncology (ESMO）
chemotherapy for cancers in head and neck cancer region and digestive system
Certified Physician, the Japanese Society of Internal Medicine
Specialist Certified by the Japanese Society of Gastroenterology
Cancer Chemotherapy Specialist Certified by the Japanese Society of Medical Oncology
chemotherapy for cancers in head and neck region and digestive system
molecular biology
Certified Physician, the Japanese Society of Internal Medicine
Cancer Chemotherapy Specialist and Supervisory Doctor Certified by the Japanese Society of Medical Oncology
The Japanese Cancer Association
The Japan Society for Head and Neck Cancer
The Japan Esophageal Society
The Japan Society of Clinical Oncology
The Japanese Society of Gastroenterology
The Japanese Association of Supportive Care in Cancer
The American Society of Clinical Oncology (ASCO)
The European Society for Medical Oncology (ESMO)
respiratory medicine
Certified Physician and Specialist, the Japanese Society of Internal Medicine
Specialist Certified by the Japanese Respiratory Society
Specialist Certified by the Japan Society for Respiratory Endoscopy
The Japanese Society of Medical Oncology
The Japan Lung Cancer Society
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
respiratory medicine
Certified Physician, the Japanese Society of Internal Medicine
The Japanese Respiratory Society
The Japan Lung Cancer Society
The Japanese Society of Medical Oncology
drug treatment for breast cancer, development of new drugs, cancer genome medicine, quality control of clinical studies, translational research
Certified Specialist for Cancer Drug Therapy and Supervisory Doctor, Councilor, the Japanese Society of Medical Oncology
Specialist Certified by the Japanese Breast Cancer Society
Registered Medical Practitioner Certified by the Japan Surgical Society
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Doctor for Radiogram Interpretation at the Breast Cancer Screening
Certified by the Japan Central Organization on Quality Assurance of Breast Cancer Screening
The Japanese Society of Internal Medicine
The Japanese Society for Hereditary Tumors
The Japan Society of Clinical Oncology
The Japan Association of Breast Cancer Screening
Regular Member, the American Society of Clinical Oncology (ASCO)
gynecological oncology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Certified Specialist and Supervisory Doctor, Editorial Committee Member for Revising the Treatment Guidelines for Uterine Corpus Cancer, the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The Japan Society of Clinical Oncology
The Japanese Cancer Association
The Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
Specialist Certified by the Japanese Society for Hereditary Tumors
Committee Member for Uterine Cervical Cancer, Qualification Committee Member for Clinical Trial and Ethical Regulations, the Japanese Gynecologic Oncology Group (JGOG)
tumors in bones and soft tissues
Specialist and Oncologist for Bones and Soft Tissues Certified by the Japanese Orthopaedic Association
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The Central Japan Association of Orthopaedic Surgery & Traumatology
The Japan Society of Clinical Oncology
The Japanese Cancer Association
pediatric cancer
support for cancer patient and his/her family
Specialist Certified by the Japan Pediatric Society
Hematologist Certified by the Japanese Society of Hematology
The Japanese Society of Pediatric Hematology/Oncology
The Japan Society for Neuro-Oncology
The Japanese Society for Transplantation and Cellular Therapy
International Member of the Children’s Oncology Group, U.S.A.
chemotherapy for gastroenterological cancer (i.e., gastrointestinal lymphoma, gastrointestinalstromal tumor (GIST))
chemotherapy for cancer in head and neck region
Certified Specialist for Cancer Chemotherapy and Supervisory Doctor for Specialist in Cancer Chemotherapy, Councilor, and Certified Interim Supervisory Doctor, the Japanese Society of Medical Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Certified Physician, Specialist and Supervisory Doctor, the Japanese Society of Internal Medicine
Specialist Certified by the Japanese Society of Gastroenterology
The Japan Society of Clinical Oncology
The American Society of Clinical Oncology (ASCO)
The Japanese Society of Hematology
The Japan Society for Head and Neck Cancer
The Japan Society for Hematopoietic Cell Transplantation
The Japan Society of Transfusion Medicine and Cell Therapy
The Japan Gastroenterological Endoscopy Society
